Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Raia Drogasil S/A

RADL3.SA ✓ COMPLIANT ☆ Track — members

B3 / Bovespa · Consumer Non-Cyclicals · Drug Retailers ·

Brazil Mid Cap Analyst: BUY

Last Close

$3.36

▼ -4.21%

Market Cap $5.92B · Vol 10.02M

Key Metrics

P/E Ratio

22.31

FWD: 16.15

Market Cap

$5.92B

Mid Cap

Div Yield

2.40%

Dividend with no set frequency

EPS Growth

+15.16%

YoY

RSI (14)

45.48

Momentum

Beta

1.12

vs Market

52W High

$5.19

35.86% below

52W Low

$3.07

13.39% above

Volume

10.02M

Avg 10.71M

P/B

5.54

Price-to-book

ROE

18.86%

Return on equity

Free Float

74.88%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Raia Drogasil S/A (RADL3.SA) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does RADL3.SA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-13.30%

-5.75%

-10.13%

-31.72%

YTD

-24.44%

+3.99%

-34.12%

-22.42%

Financials & Valuation

TTM · Annual

Total Revenue	$8.08B
Net Income	$237.40M
Revenue Growth (YoY)	+9.80%
Gross Margin	29.30%
Operating Margin	6.05%
Net Profit Margin	2.94%
ROE	18.86%
ROA · ROIC	6.12% · 14.74%

P/E Ratio	22.31
Forward P/E (FY1)	16.15
PEG Ratio	2.96
P/S	0.87
P/B	5.54
P/FCF	37.44
EPS Growth	+15.16%
Outstanding Shares	1.75B

Technical Indicators

50-Day SMA	$3.43
200-Day SMA	$4.10
RSI (14)	45.48
Beta	1.12
52-Week High	$5.19
52-Week Low	$3.07

Volume Today	10.02M
Avg Daily Volume (30D)	10.71M
Relative Volume	0.93x
Volatility (10D)	55.40
Volatility (30D)	42.12
Free Float	74.88%

Analyst Consensus

BUY

Current Price $3.36

Mean Target $5.06

52W Low$3.07 52W High$5.19

Current

Target

$3.07 $5.19

Current Analyst target

+50.74% upside potential · 11 analysts

Identifiers

ExchangeB3 / Bovespa

FIGIBBG001S739F2

ISINBRRADLACNOR0

CountryBrazil

Sub-IndustryRetail - Drugs without Grocery

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

3341.T Nihon Chouzai Co Ltd -0.38% 3034.T Qol Holdings Co Ltd +6.80% PETS Petmed Express Inc -10.10% 6618.HK JD Health International Inc -0.05% 3391.T Tsuruha Holdings Inc +0.59%

Company Profile

Raia Drogasil S/A is a Brazil-based company, headquartered in Sao Paulo. Its main activity is the retail sale of pharmaceutical and cosmetic products, including branded medications, generic medications, OTC (over-the-counter) medications, non-medications (such as personal hygiene products, cosmetics, and dermocosmetics), and various services. The Company has a presence in all federal units of the country, demonstrating its coverage and accessibility. Additionally, the digitalization of the customer journey has been a crucial factor in the Company's growth, enabling a more convenient and efficient shopping experience. The expansion of physical pharmacies, combined with digital solutions, has significantly contributed to Raia Drogasil's continued growth in the Brazilian market.